RAD 501
Alternative Names: RAD-501Latest Information Update: 28 Jun 2022
At a glance
- Originator Radiopharm Theranostics
- Class Diagnostic agents; Immunoconjugates
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Osteosarcoma